Colin Shannon, EVP, Global Clinical Operations at PHARMACEUTICAL PRODUCT DEVELOPMENT INC (PPDI), sold 9,667 shares at $35.12 ($340K) on 2007-05-04, disclosed to the SEC on 2007-05-07.
Open-market sale of $340k PPDI by EVP, Global Clinical Operations. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.12 | 6,800 | $239K | 70.3% |
| 2 | $35.13 | 900 | $32K | 9.3% |
| 3 | $35.14 | 246 | $9K | 2.5% |
| 4 | $35.15 | 83 | $3K | 0.9% |
| 5 | $35.16 | 338 | $12K | 3.5% |
| 6 | $35.17 | 1,300 |
| $46K |
| 13.5% |
| Total | $35.13 avg | 9,667 | $340K | 100% |
| Filing → |
| PRAH | SELL | 2021-06-17 | $62.9M | — | Filing → |
| PRAH | SELL | 2021-06-03 | $2.2M | — | Filing → |
| PRAH | SELL | 2020-08-17 | $1.2M | — | Filing → |